<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-205-9-29-38</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Факторы риска рака желудка как основа разработки прогностической карты для регистра больных с предраковыми гастродуоденальными заболеваниями</article-title><trans-title-group xml:lang="en"><trans-title>Risk factors of gastric cancer as a basis for the development of a prognostic questionnaire for the register of patients with precancerous gastroduodenal diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9134-931X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барановский</surname><given-names>Андрей Юрьевич</given-names></name><name name-style="western" xml:lang="en"><surname>Baranovskiy</surname><given-names>A. Yu.</given-names></name></name-alternatives><email xlink:type="simple">baranovsky46@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6684-0422</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цветкова</surname><given-names>Татьяна Лазаревна</given-names></name><name name-style="western" xml:lang="en"><surname>Tcvetkova</surname><given-names>T. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «Новел СПб»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novel SPb LLC</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2022</year></pub-date><volume>0</volume><issue>9</issue><fpage>29</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Барановский А.Ю., Цветкова Т.Л., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Барановский А.Ю., Цветкова Т.Л.</copyright-holder><copyright-holder xml:lang="en">Baranovskiy A.Y., Tcvetkova T.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2036">https://www.nogr.org/jour/article/view/2036</self-uri><abstract><p>Статья представляет собой критический анализ мировой научной литературы, посвященной поиску факторов риска возникновения рака желудка для своевременного прогноза этого заболевания и проведения мероприятий канцеропревенции. В работе приведены данные многочисленных исследований по определению роли факторов внешней среды, в том числе неблагоприятной экологии, а также пола, возраста, курения, злоупотребления алкоголем. Представлены мнения авторов о существенной роли в генезе новообразований в желудке алиментарного фактора, в том числе преобладания в пище животных жиров, злоупотребления пережаренной, маринованной пищи, богатой нитрозоаминами, насыщенными пряностями продуктами, употребления слишком горячей пищи, использования в питании продуктов, зараженных микотоксинами. Отмечена роль факторов внутренней среды в прогнозе рака желудка: состояние секреторной активности желудка, динамика воспалительных и атрофических процессов в слизистой оболочке. Особая роль для прогноза рака желудка многими авторами отводится пилорическому геликобактеру, а также количественному показателю гликозированного гемоглобина крови и его динамике. Неоднозначно значение генетических изменений в генезе рака желудка и их роль как факторов прогноза заболевания. В статье обращено внимание на разнонаправленные результаты многих авторов в осмыслении большого числа ими изученных факторов, которые могли бы быть использованы в качестве прогностических свидетелей рака желудка. Обосновывается целесообразность поиска наиболее значимых региональных факторов прогноза рака желудка, на основе которых очень важно создавать регистры больных с предраковыми заболеваниями желудка для организации и проведения персонифицированных и действенных мероприятий канцеропревенции.</p></abstract><trans-abstract xml:lang="en"><p>The article is a critical analysis of the world scientific literature devoted to the search for risk factors for stomach cancer for the timely prognosis of this disease and the implementation of cancer prevention measures. The paper presents data from numerous studies to determine the role of environmental factors, including unfavorable ecology, as well as gender, age, smoking, alcohol abuse. The authors’ opinions are presented on the essential role of the alimentary factor in the genesis of neoplasms in the stomach, including the predominance of animal fats in food, the abuse of overcooked, pickled foods rich in nitrosoamines, foods saturated with spices, the use of too hot food, the use of foods infected with mycotoxins in nutrition. The role of environmental factors in the prognosis of gastric cancer is noted: the state of secretory activity of the stomach, the dynamics of inflammatory and atrophic processes in the mucous membrane. A special role for the prognosis of stomach cancer is assigned by many authors to the pyloric helicobacter, as well as the quantitative indicator of glycated blood hemoglobin and its dynamics. The significance of genetic changes in the genesis of gastric cancer and their role as prognostic factors of the disease is ambiguous. The article draws attention to the multidirectional results of many authors in understanding a large number of factors they have studied that could be used as prognostic witnesses of stomach cancer. The expediency of searching for the most significant regional factors for the prognosis of gastric cancer is substantiated, on the basis of which it is very important to create registers of patients with precancerous diseases of the stomach for the organization and implementation of personalized and effective measures of cancer prevention.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>pак желудка</kwd><kwd>факторы риска</kwd><kwd>предраковые заболевания</kwd><kwd>прогноз рака желудка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stomach cancer</kwd><kwd>risk factors</kwd><kwd>precancerous diseases</kwd><kwd>prognosis of stomach cancer</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bray F. B., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018, no. 70, pp. 313. doi: 10.3322/caac.21492.</mixed-citation><mixed-citation xml:lang="en">Bray F. B., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018, no. 70, pp. 313. doi: 10.3322/caac.21492.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kaprin A., Starinskiy V., Shakhzadova A., et al. The state of cancer care for the population of Russia in 2018. - Moscow: MNIOI them. P. A. Herzen - branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2019. (in Russ.) ISBN 5-85502-024-X @@Каприн А. Д., В. В. Старинский В. В., Шахзадова А. О. (Ред.) Состояние онкологической помощи населению России в 2018 году. - Москва: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019.</mixed-citation><mixed-citation xml:lang="en">Kaprin A., Starinskiy V., Shakhzadova A., et al. The state of cancer care for the population of Russia in 2018. - Moscow: MNIOI them. P. A. Herzen - branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2019. (in Russ.) ISBN 5-85502-024-X @@Каприн А. Д., В. В. Старинский В. В., Шахзадова А. О. (Ред.) Состояние онкологической помощи населению России в 2018 году. - Москва: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Besova N., Kalinin A., Nered S., et al. Stomach cancer. Clinical guidelines. Moscow, 2020. КР574 (in Russ.) @@Бесова Н. С., Калинин А. Е., Неред С. Н. и соавт. Рак желудка. Клинические рекомендации. М., 2020</mixed-citation><mixed-citation xml:lang="en">Besova N., Kalinin A., Nered S., et al. Stomach cancer. Clinical guidelines. Moscow, 2020. КР574 (in Russ.) @@Бесова Н. С., Калинин А. Е., Неред С. Н. и соавт. Рак желудка. Клинические рекомендации. М., 2020</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">GLOBOCAN 2020 Graph production: IARC (https://gco.iarc.fr/today) World Health Organization</mixed-citation><mixed-citation xml:lang="en">GLOBOCAN 2020 Graph production: IARC (https://gco.iarc.fr/today) World Health Organization</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kaprin A., Starinskiy V., Shakhzadova A., et al. The state of cancer care for the population of Russia in 2019, M. MNIOI them. P. A. Herzen - branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2020, pp. 239. (in Russ.) @@Каприн А. Д., В. В. Старинский В. В., Шахзадова А. О. (Ред.) Состояние онкологической помощи населению России в 2019 году. - М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. - 239 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A., Starinskiy V., Shakhzadova A., et al. The state of cancer care for the population of Russia in 2019, M. MNIOI them. P. A. Herzen - branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia, 2020, pp. 239. (in Russ.) @@Каприн А. Д., В. В. Старинский В. В., Шахзадова А. О. (Ред.) Состояние онкологической помощи населению России в 2019 году. - М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. - 239 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Taninaga J., Nishiyama Y., Fujibayashi K., et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Scientific Reports, 2019, no.9, pp. 1-9. doi: 10.1038/s41598-019-48769.</mixed-citation><mixed-citation xml:lang="en">Taninaga J., Nishiyama Y., Fujibayashi K., et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Scientific Reports, 2019, no.9, pp. 1-9. doi: 10.1038/s41598-019-48769.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yang P., Zhou Y., Chen B., et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. European journal of cancer, 2009, no. 45, pp. 2867-2873. doi: 10.1016/j.ejca.2009.04.019.</mixed-citation><mixed-citation xml:lang="en">Yang P., Zhou Y., Chen B., et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. European journal of cancer, 2009, no. 45, pp. 2867-2873. doi: 10.1016/j.ejca.2009.04.019.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue M., Iwasaki M., Otani T., et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Archives of internal medicine. 2006, no. 166, pp. 1871-1877. doi: 10.1001/archinte.166.17.1871.</mixed-citation><mixed-citation xml:lang="en">Inoue M., Iwasaki M., Otani T., et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Archives of internal medicine. 2006, no. 166, pp. 1871-1877. doi: 10.1001/archinte.166.17.1871.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ilson D. H. Advances in the treatment of gastric cancer. Current opinion in gastroenterology. 2017, no. 33, pp. 473-476. doi: 10.1097/MOG.0000000000000475.</mixed-citation><mixed-citation xml:lang="en">Ilson D. H. Advances in the treatment of gastric cancer. Current opinion in gastroenterology. 2017, no. 33, pp. 473-476. doi: 10.1097/MOG.0000000000000475.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kim G.H., Liang, P.S., Bang S. J., et al. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointestinal endoscopy. 2016, no. 84, pp. 18-28. doi: 10.1016/j.gie.2016.02.028.</mixed-citation><mixed-citation xml:lang="en">Kim G.H., Liang, P.S., Bang S. J., et al. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointestinal endoscopy. 2016, no. 84, pp. 18-28. doi: 10.1016/j.gie.2016.02.028.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cai Q., Zhu C., Yuan Y., et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut, 2019, no. 68, pp. 1576-1587. doi: 10.1136/gutjnl-2018-317556.</mixed-citation><mixed-citation xml:lang="en">Cai Q., Zhu C., Yuan Y., et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut, 2019, no. 68, pp. 1576-1587. doi: 10.1136/gutjnl-2018-317556.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yaghoobi M., Mcnabb-Baltar J., Bijarchi R., et al. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World journal of gastroenterology. 2017, no. 23, pp. 2435-42. doi: 10.3748/wjg.v23.i13.2435.</mixed-citation><mixed-citation xml:lang="en">Yaghoobi M., Mcnabb-Baltar J., Bijarchi R., et al. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World journal of gastroenterology. 2017, no. 23, pp. 2435-42. doi: 10.3748/wjg.v23.i13.2435.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bernini M., Barbi S., Roviello F., et al. Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. Gastric Cancer. 2006, no. 9, pp. 9-13. doi: 10.1007/s10120-005-0350-7.</mixed-citation><mixed-citation xml:lang="en">Bernini M., Barbi S., Roviello F., et al. Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. Gastric Cancer. 2006, no. 9, pp. 9-13. doi: 10.1007/s10120-005-0350-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tu H., Sun L., Dong X., et al. А Serological Biopsy Using Five Stomach-Specific circulating Biomarkers for gastric cancer risk assessment: a Multi-Phase Study. American Journal of Gastroenterology, 2017, no. 112, pp. 704-715. doi:10.1038/ajg.2017.55.</mixed-citation><mixed-citation xml:lang="en">Tu H., Sun L., Dong X., et al. А Serological Biopsy Using Five Stomach-Specific circulating Biomarkers for gastric cancer risk assessment: a Multi-Phase Study. American Journal of Gastroenterology, 2017, no. 112, pp. 704-715. doi:10.1038/ajg.2017.55.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hua X. Сonsensus on screening and endoscopic diagnosis and treatment of early gastric cancer in Сhina. Chinese society of digestive endoscopy. 2014, no. 31, pp. 361-77. doi:10.1155/2016/9638041.</mixed-citation><mixed-citation xml:lang="en">Hua X. Сonsensus on screening and endoscopic diagnosis and treatment of early gastric cancer in Сhina. Chinese society of digestive endoscopy. 2014, no. 31, pp. 361-77. doi:10.1155/2016/9638041.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori igg antibody and serum pepsinogen levels - “aBc method”. Proceedings of the Japan Academy. 2011, no. 87, pp. 405-14. doi: 10.2183/pjab.87.405.</mixed-citation><mixed-citation xml:lang="en">Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori igg antibody and serum pepsinogen levels - “aBc method”. Proceedings of the Japan Academy. 2011, no. 87, pp. 405-14. doi: 10.2183/pjab.87.405.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Watabe H., Mitsushima T., Yamaji Y., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005, no. 54, pp. 764-8. doi: 10.1136/gut.2004.055400.</mixed-citation><mixed-citation xml:lang="en">Watabe H., Mitsushima T., Yamaji Y., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005, no. 54, pp. 764-8. doi: 10.1136/gut.2004.055400.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Leung W. K., Wu M. S., Kakugawa Y., et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncology. 2008, no. 9, pp. 279-87. doi: 10.1016/S1470-2045(08)70072-X.</mixed-citation><mixed-citation xml:lang="en">Leung W. K., Wu M. S., Kakugawa Y., et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncology. 2008, no. 9, pp. 279-87. doi: 10.1016/S1470-2045(08)70072-X.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chen W., Zheng R., Baade P. D., et al. Cancer statistics in china, 2015. CA: a cancer journal for clinicians. 2016, no. 66, pp. 115-32. doi: 10.3322/caac.21338.</mixed-citation><mixed-citation xml:lang="en">Chen W., Zheng R., Baade P. D., et al. Cancer statistics in china, 2015. CA: a cancer journal for clinicians. 2016, no. 66, pp. 115-32. doi: 10.3322/caac.21338.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chun N., Ford J. Genetic testing in stomach cancer. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams &amp; Wilkins; 2015.</mixed-citation><mixed-citation xml:lang="en">Chun N., Ford J. Genetic testing in stomach cancer. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams &amp; Wilkins; 2015.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rawla P., Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przeglad Gastroenterologiczny. 2019, no. 14, pp. 26-38. doi: 10.5114/pg.2018.80001.</mixed-citation><mixed-citation xml:lang="en">Rawla P., Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przeglad Gastroenterologiczny. 2019, no. 14, pp. 26-38. doi: 10.5114/pg.2018.80001.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Correa P. The biological model of gastric carcinogenesis. JARC Scientific publications. 2004, no. 157, pp. 301-310. PMID: 15055303.</mixed-citation><mixed-citation xml:lang="en">Correa P. The biological model of gastric carcinogenesis. JARC Scientific publications. 2004, no. 157, pp. 301-310. PMID: 15055303.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sipponen P. Gastric cancer: pathogenesis, risks, and prevention. Journal gastroenterology. 2002, no. 37, pp. 39-44. doi: 10.1007/BF02990098.</mixed-citation><mixed-citation xml:lang="en">Sipponen P. Gastric cancer: pathogenesis, risks, and prevention. Journal gastroenterology. 2002, no. 37, pp. 39-44. doi: 10.1007/BF02990098.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Sipponen P., Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer. 2002, no. 5, pp. 213-9.</mixed-citation><mixed-citation xml:lang="en">Sipponen P., Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer. 2002, no. 5, pp. 213-9.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ma L., Chow J. Y., Cho C. H. Effects of cigarette smoking on gastric ulcer formation and healing: possible mechanisms of action. Jornal of clinical gastroenterology. 1998, no. 27, pp. 80. doi: 10.1097/00004836-199800001-00013.</mixed-citation><mixed-citation xml:lang="en">Ma L., Chow J. Y., Cho C. H. Effects of cigarette smoking on gastric ulcer formation and healing: possible mechanisms of action. Jornal of clinical gastroenterology. 1998, no. 27, pp. 80. doi: 10.1097/00004836-199800001-00013.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ferro A., Morais S., Rota M., et al. Tobacco smoking and gastric cancer: meta-analyses of published data versus pooled analyses of individual participant data. European journal of cancer prevention. 2018, no. 27, pp. 197-204. doi: 10.1097/CEJ.0000000000000401.</mixed-citation><mixed-citation xml:lang="en">Ferro A., Morais S., Rota M., et al. Tobacco smoking and gastric cancer: meta-analyses of published data versus pooled analyses of individual participant data. European journal of cancer prevention. 2018, no. 27, pp. 197-204. doi: 10.1097/CEJ.0000000000000401.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Han F., Wang X., Wang X., et al. Meta-analysis of the association of cYP1a1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking. Molecular Biology Reports. 2012, no. 39, pp. 8335-8344. doi: 10.1007/s11033-012-1683-z.</mixed-citation><mixed-citation xml:lang="en">Han F., Wang X., Wang X., et al. Meta-analysis of the association of cYP1a1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking. Molecular Biology Reports. 2012, no. 39, pp. 8335-8344. doi: 10.1007/s11033-012-1683-z.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">La TorreG., Chiaradia G., Gianfagna F., et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori. 2009, no. 95, pp. 13-22. doi: 10/1700/410.4843.</mixed-citation><mixed-citation xml:lang="en">La TorreG., Chiaradia G., Gianfagna F., et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori. 2009, no. 95, pp. 13-22. doi: 10/1700/410.4843.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ladeiras-Lopes R., Kirchhofer Pereira A., Nogueira A., et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008, no. 19, pp. 689-701. doi: 10.1007/s10552-008-9132-y.</mixed-citation><mixed-citation xml:lang="en">Ladeiras-Lopes R., Kirchhofer Pereira A., Nogueira A., et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008, no. 19, pp. 689-701. doi: 10.1007/s10552-008-9132-y.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007. 10(2):75-83. doi: 10.1007/s10120-007-0420-0.</mixed-citation><mixed-citation xml:lang="en">Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007. 10(2):75-83. doi: 10.1007/s10120-007-0420-0.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000, no. 3, pp. 219-225. doi: 10.1007/pl00011720.</mixed-citation><mixed-citation xml:lang="en">Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000, no. 3, pp. 219-225. doi: 10.1007/pl00011720.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chernousov A., Polikarpov S., Gozhelo E. Early cancer and precancerous diseases of the stomach. Moscow. IzdAT Publ., 2002, 256 P. (in Russ.) ISBN 5-86656-136-0. @@Черноусов А. Ф., Поликарпов С. А., Годжело Э. А. Ранний рак и предопухолевые заболевания желудка - М.: ИздАТ, 2002. -256 с.</mixed-citation><mixed-citation xml:lang="en">Chernousov A., Polikarpov S., Gozhelo E. Early cancer and precancerous diseases of the stomach. Moscow. IzdAT Publ., 2002, 256 P. (in Russ.) ISBN 5-86656-136-0. @@Черноусов А. Ф., Поликарпов С. А., Годжело Э. А. Ранний рак и предопухолевые заболевания желудка - М.: ИздАТ, 2002. -256 с.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nashimoto A., Akazawa K., Isobe Y., et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013, no.16, pp. 1-27. doi: 10.1007/s10120-012-0163-4</mixed-citation><mixed-citation xml:lang="en">Nashimoto A., Akazawa K., Isobe Y., et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013, no.16, pp. 1-27. doi: 10.1007/s10120-012-0163-4</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Schepotin I., Evans S. Stomach cancer: a practical guide to prevention, diagnosis and treatment. Kiev “Book Plus” 2000, 227 P. (in Russ.) ISBN 966-7619-00-1. @@Щепотин И. Б., Эванс С. Р. Рак желудка: практическое руководство по профилактике, диагностике и лечению. Киев “Книга Плюс” 2000. - 227 с.</mixed-citation><mixed-citation xml:lang="en">Schepotin I., Evans S. Stomach cancer: a practical guide to prevention, diagnosis and treatment. Kiev “Book Plus” 2000, 227 P. (in Russ.) ISBN 966-7619-00-1. @@Щепотин И. Б., Эванс С. Р. Рак желудка: практическое руководство по профилактике, диагностике и лечению. Киев “Книга Плюс” 2000. - 227 с.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Besova N., Tryakin A., Artamonova E., et al. Practical recommendations for drug treatment of stomach cancer. Malignant tumors. 2020;10(3s2-1): 334-349. (in Russ.) doi: 10.18027 / 2224-5057-2020-10-3s2-21. @@Бесова Н. С., Трякин А. А., Артамонова Е. В. и др. Практические рекомендации по лекарственному лечению рака желудка. Злокачественные опухоли. 2020;10(3s2-1):334-349. doi: 10.18027/2224-5057-2020-10-3s2-21.</mixed-citation><mixed-citation xml:lang="en">Besova N., Tryakin A., Artamonova E., et al. Practical recommendations for drug treatment of stomach cancer. Malignant tumors. 2020;10(3s2-1): 334-349. (in Russ.) doi: 10.18027 / 2224-5057-2020-10-3s2-21. @@Бесова Н. С., Трякин А. А., Артамонова Е. В. и др. Практические рекомендации по лекарственному лечению рака желудка. Злокачественные опухоли. 2020;10(3s2-1):334-349. doi: 10.18027/2224-5057-2020-10-3s2-21.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao Hua, Zhonghua Nei, Jing Za Zhi. Сonsensus on screening and endoscopic diagnosis and treatment of early gastric cancer in Сhina (Сhangsha, 2014). Сhinese Society of Digestive endoscopy. 2014, no. 31, pp. 361-77. doi: 10.3969/j.issn.1008-7125.2014.07.006.</mixed-citation><mixed-citation xml:lang="en">Xiao Hua, Zhonghua Nei, Jing Za Zhi. Сonsensus on screening and endoscopic diagnosis and treatment of early gastric cancer in Сhina (Сhangsha, 2014). Сhinese Society of Digestive endoscopy. 2014, no. 31, pp. 361-77. doi: 10.3969/j.issn.1008-7125.2014.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zaridze D. Epidemiology and etiology of malignant diseases. Carcinogenesis. Moscow. Scientific world Publ., 2000. @@Заридзе Д. Г. Эпидемиология и этиология злокачественных заболеваний// Заридзе Д. Г. Канцерогенез. - Москва: Научный мир, 2000.</mixed-citation><mixed-citation xml:lang="en">Zaridze D. Epidemiology and etiology of malignant diseases. Carcinogenesis. Moscow. Scientific world Publ., 2000. @@Заридзе Д. Г. Эпидемиология и этиология злокачественных заболеваний// Заридзе Д. Г. Канцерогенез. - Москва: Научный мир, 2000.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007, no. 10, pp. 75-83. doi: 10.1007/s10120-007-0420-0.</mixed-citation><mixed-citation xml:lang="en">Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007, no. 10, pp. 75-83. doi: 10.1007/s10120-007-0420-0.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Rumgay H., Shield K., Charvat H., et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021, no. 22, pp. 1071-1080. doi: 10.1016/S1470-2045(21)00279-5.</mixed-citation><mixed-citation xml:lang="en">Rumgay H., Shield K., Charvat H., et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021, no. 22, pp. 1071-1080. doi: 10.1016/S1470-2045(21)00279-5.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson D. E., Jarman D. W., Rehm J., et al. Alcohol-Attributable Cancer Deaths and Years of Potential Life Lost in the United States. American journal of public health. 2013, no. 103, pp. 641-648. doi: 10.2105/AJPH.2012.301199.</mixed-citation><mixed-citation xml:lang="en">Nelson D. E., Jarman D. W., Rehm J., et al. Alcohol-Attributable Cancer Deaths and Years of Potential Life Lost in the United States. American journal of public health. 2013, no. 103, pp. 641-648. doi: 10.2105/AJPH.2012.301199.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue M., Iwasaki M., Otani T., et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Archives of internal medicine. 2006, no. 166, pp. 1871-7. doi: 10.1001/archinte.166.17.1871.</mixed-citation><mixed-citation xml:lang="en">Inoue M., Iwasaki M., Otani T., et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Archives of internal medicine. 2006, no. 166, pp. 1871-7. doi: 10.1001/archinte.166.17.1871.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Yang P., Zhou Y., Chen B., et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Europian journal of cancer. 2009, no. 45, pp. 2867-2873. doi: 10.1016/j.ejca.2009.04.019.</mixed-citation><mixed-citation xml:lang="en">Yang P., Zhou Y., Chen B., et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Europian journal of cancer. 2009, no. 45, pp. 2867-2873. doi: 10.1016/j.ejca.2009.04.019.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Taninaga J., Nishiyama Y., Fujibayashi K., et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: A case-control study. Scientific reports. 2019, no. 9, pp. 12384. doi: 10.1038/s41598-019-48769-y.</mixed-citation><mixed-citation xml:lang="en">Taninaga J., Nishiyama Y., Fujibayashi K., et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: A case-control study. Scientific reports. 2019, no. 9, pp. 12384. doi: 10.1038/s41598-019-48769-y.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Nie Y., Wu K., Yu J., et al. a global burden of gastric cancer: the major impact of china. Expert Rev Gastroenterol Hepatol, 2017, no. 11, pp. 651-61. doi: 10.1080/17474124.2017.1312342.</mixed-citation><mixed-citation xml:lang="en">Nie Y., Wu K., Yu J., et al. a global burden of gastric cancer: the major impact of china. Expert Rev Gastroenterol Hepatol, 2017, no. 11, pp. 651-61. doi: 10.1080/17474124.2017.1312342.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Cai Q., Yu E. D., Xiao Y., et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk chinese. Am J Epidemiol. 2012; 175:584-93. doi: 10.1093/aje/kwr337.</mixed-citation><mixed-citation xml:lang="en">Cai Q., Yu E. D., Xiao Y., et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk chinese. Am J Epidemiol. 2012; 175:584-93. doi: 10.1093/aje/kwr337.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Zagari rM., Rabitti S., Greenwood Dc., et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and antiHelicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017; 46:657-67. doi: 10.1111/apt.14248.</mixed-citation><mixed-citation xml:lang="en">Zagari rM., Rabitti S., Greenwood Dc., et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and antiHelicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017; 46:657-67. doi: 10.1111/apt.14248.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Leung W. K., Wu M. S., Kakugawa Y., et al. Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008; 9:279-87. doi: 10.1016/S1470-2045(08)70072-X.</mixed-citation><mixed-citation xml:lang="en">Leung W. K., Wu M. S., Kakugawa Y., et al. Asia Pacific Working Group on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008; 9:279-87. doi: 10.1016/S1470-2045(08)70072-X.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Chiang T.H., Chiu S. Y., Chen S.l., et al. Serum Pepsinogen as a Predictor for gastric cancer Death: a 16-Year community-based cohort Study. J Clin Gastroenterol. May/Jun 2019;53(5): e186-e193. doi: 10.1097/MCG.000000000000099.</mixed-citation><mixed-citation xml:lang="en">Chiang T.H., Chiu S. Y., Chen S.l., et al. Serum Pepsinogen as a Predictor for gastric cancer Death: a 16-Year community-based cohort Study. J Clin Gastroenterol. May/Jun 2019;53(5): e186-e193. doi: 10.1097/MCG.000000000000099.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lin E., Bian H., Chen C., et al. Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. J Gastrointest Oncol. 2021 Jun; 12(3): 1042-1048. doi: 10.21037/jgo-21-254.</mixed-citation><mixed-citation xml:lang="en">Lin E., Bian H., Chen C., et al. Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. J Gastrointest Oncol. 2021 Jun; 12(3): 1042-1048. doi: 10.21037/jgo-21-254.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Karimi P., Islami F., Anandasabapathy S., et al. gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-13. doi: 10.1158/1055-9965.EPI-13-1057.</mixed-citation><mixed-citation xml:lang="en">Karimi P., Islami F., Anandasabapathy S., et al. gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-13. doi: 10.1158/1055-9965.EPI-13-1057.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Sun L., Tu H., Liu J., et al. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in chinese population. Scand J Gastroenterol. 2014;49:1164-72. doi: 10.3109/00365521.2014.950693.</mixed-citation><mixed-citation xml:lang="en">Sun L., Tu H., Liu J., et al. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in chinese population. Scand J Gastroenterol. 2014;49:1164-72. doi: 10.3109/00365521.2014.950693.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Kurilovich S, Belkovets A, Reshetnikov O., et al. Stomach-specific Biomarkers (gastroPanel) can Predict the Development of gastric cancer in a caucasian Population: a longitudinal nested case-control Study in Siberia. Anticancer Res. 2016;36:247-53. PMID: 26722050.</mixed-citation><mixed-citation xml:lang="en">Kurilovich S, Belkovets A, Reshetnikov O., et al. Stomach-specific Biomarkers (gastroPanel) can Predict the Development of gastric cancer in a caucasian Population: a longitudinal nested case-control Study in Siberia. Anticancer Res. 2016;36:247-53. PMID: 26722050.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Haj-Sheykholeslami A., Rakhshani N., Amirzargar A., et al. Serum pepsinogen i, pepsinogen ii, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol. 2008;6:174-9. doi: 10.1016/j.cgh.2007.11.016.</mixed-citation><mixed-citation xml:lang="en">Haj-Sheykholeslami A., Rakhshani N., Amirzargar A., et al. Serum pepsinogen i, pepsinogen ii, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol. 2008;6:174-9. doi: 10.1016/j.cgh.2007.11.016.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Sawada M., Dickinson C. J. The G-cell. Annu Rev Physiol. 1997; 59:273-98. doi: 10.1146/annurev.physiol.59.1.273.</mixed-citation><mixed-citation xml:lang="en">Sawada M., Dickinson C. J. The G-cell. Annu Rev Physiol. 1997; 59:273-98. doi: 10.1146/annurev.physiol.59.1.273.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T. C., Dangler C. A., Chen D., et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000; 118:36-47. doi: 10.1016/s0016-5085(00)70412-4.</mixed-citation><mixed-citation xml:lang="en">Wang T. C., Dangler C. A., Chen D., et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000; 118:36-47. doi: 10.1016/s0016-5085(00)70412-4.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Silvis S., Nebel E., Rogers O., et al. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA. 1976, no. 235, pp. 928-930. doi: 10.1001/jama.235.9.928.</mixed-citation><mixed-citation xml:lang="en">Silvis S., Nebel E., Rogers O., et al. Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA. 1976, no. 235, pp. 928-930. doi: 10.1001/jama.235.9.928.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">ASGE Standards of Practice Committee, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest. Endosc. 2015; 82: 1-8, doi: 10.1016/j.gie.2015.03.1967.</mixed-citation><mixed-citation xml:lang="en">ASGE Standards of Practice Committee, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest. Endosc. 2015; 82: 1-8, doi: 10.1016/j.gie.2015.03.1967.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Correa P. A human model of gastric carcinogenesis. Cancer Research. 1988, no. 48, pp. 3554-3560. PMID: 3288329.</mixed-citation><mixed-citation xml:lang="en">Correa P. A human model of gastric carcinogenesis. Cancer Research. 1988, no. 48, pp. 3554-3560. PMID: 3288329.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 1994, 61, 1-241. PMCID: PMC7681621.</mixed-citation><mixed-citation xml:lang="en">Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 1994, 61, 1-241. PMCID: PMC7681621.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Alimentary pharmacology and therapeutics. 2013. no. 37, pp. 375-382. doi: 10.1111/apt.12177.</mixed-citation><mixed-citation xml:lang="en">Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Alimentary pharmacology and therapeutics. 2013. no. 37, pp. 375-382. doi: 10.1111/apt.12177.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Feng F., Zheng G., Wang Q., et al. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer. BMC Gastroenterology. 2018. no. 18, pp. 148. doi: 10.1186/s12876-018-0877-9.</mixed-citation><mixed-citation xml:lang="en">Feng F., Zheng G., Wang Q., et al. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer. BMC Gastroenterology. 2018. no. 18, pp. 148. doi: 10.1186/s12876-018-0877-9.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Y., Xu H., Jiang H., Ding S., Zheng T. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence. Cancer biomarkers: section A of disease markers. 2016. no. 16, pp. 523-528. doi: 10.3233/CBM-160593.</mixed-citation><mixed-citation xml:lang="en">Jiang Y., Xu H., Jiang H., Ding S., Zheng T. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence. Cancer biomarkers: section A of disease markers. 2016. no. 16, pp. 523-528. doi: 10.3233/CBM-160593.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Takeno S., HashimotoT., Maki K., et al. Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World journal of gastroenterology. 2014. no. 20, pp. 13734-13740. doi: 10.3748/wjg.v20.i38.13734.</mixed-citation><mixed-citation xml:lang="en">Takeno S., HashimotoT., Maki K., et al. Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World journal of gastroenterology. 2014. no. 20, pp. 13734-13740. doi: 10.3748/wjg.v20.i38.13734.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Ilson D. H. Advances in the treatment of gastric cancer. Curr. Opin. Gastroenterol. 2018; 33: 473-476. doi: 10.1097/MOG.0000000000000475.</mixed-citation><mixed-citation xml:lang="en">Ilson D. H. Advances in the treatment of gastric cancer. Curr. Opin. Gastroenterol. 2018; 33: 473-476. doi: 10.1097/MOG.0000000000000475.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Boland C. R., Yurgelun M. B. Historical perspective on familial gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;3:192-200. doi: 10.1016/j.jcmgh.2016.12.003.</mixed-citation><mixed-citation xml:lang="en">Boland C. R., Yurgelun M. B. Historical perspective on familial gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;3:192-200. doi: 10.1016/j.jcmgh.2016.12.003.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Woods S. L., Healey S., et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet. 2016; 98:830-42. doi: 10.1016/j.ajhg.2016.03.001.</mixed-citation><mixed-citation xml:lang="en">Li J., Woods S. L., Healey S., et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet. 2016; 98:830-42. doi: 10.1016/j.ajhg.2016.03.001.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer, 2016. Revised 2018.</mixed-citation><mixed-citation xml:lang="en">World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer, 2016. Revised 2018.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Balakrishnan M., George R., Sharma A., Graham D. Y. Changing trends in stomach cancer throughout the world. Current gastroenterology reports. 2017. No. 19, pp. 36. doi: 10.1007/s11894-017-0575-8.</mixed-citation><mixed-citation xml:lang="en">Balakrishnan M., George R., Sharma A., Graham D. Y. Changing trends in stomach cancer throughout the world. Current gastroenterology reports. 2017. No. 19, pp. 36. doi: 10.1007/s11894-017-0575-8.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Avanesyan A., Sokolenko A., Ivantsov A., et al. Stomach cancer in carriers of the BRCA1 germline mutation: results of endoscopic screening and molecular analysis of tumor tissues. Pathobiology, 2020, no. 87, pp. 367-374. (in Russ.) doi: 10.1159/000511323. @@Аванесян А. А., Соколенко А. П., Иванцов А. И. и др. Рак желудка у носителей мутации зародышевой линии BRCA1: результаты эндоскопического скрининга и молекулярного анализа опухолевых тканей/ Патобиология, 2020. - № 87 (6), с. 367-374.</mixed-citation><mixed-citation xml:lang="en">Avanesyan A., Sokolenko A., Ivantsov A., et al. Stomach cancer in carriers of the BRCA1 germline mutation: results of endoscopic screening and molecular analysis of tumor tissues. Pathobiology, 2020, no. 87, pp. 367-374. (in Russ.) doi: 10.1159/000511323. @@Аванесян А. А., Соколенко А. П., Иванцов А. И. и др. Рак желудка у носителей мутации зародышевой линии BRCA1: результаты эндоскопического скрининга и молекулярного анализа опухолевых тканей/ Патобиология, 2020. - № 87 (6), с. 367-374.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Ilson D. H. Advances in the treatment of gastric cancer. Curr. Opin. Gastroenterol. 2017. 33, 473-476. doi: 10.1097/MOG.0000000000000395.</mixed-citation><mixed-citation xml:lang="en">Ilson D. H. Advances in the treatment of gastric cancer. Curr. Opin. Gastroenterol. 2017. 33, 473-476. doi: 10.1097/MOG.0000000000000395.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Leja M., You W., Camargo M. C., et al. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093-106. doi: 10.1016/j.bpg.2014.09.005.</mixed-citation><mixed-citation xml:lang="en">Leja M., You W., Camargo M. C., et al. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093-106. doi: 10.1016/j.bpg.2014.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Kim G. H., Liang P. S., Bang S. J., Hwang J. H. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointestinal endoscopy. 2016. no. 84, pp.18-28. doi: 10.1016/j.gie.2016.02.028.</mixed-citation><mixed-citation xml:lang="en">Kim G. H., Liang P. S., Bang S. J., Hwang J. H. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointestinal endoscopy. 2016. no. 84, pp.18-28. doi: 10.1016/j.gie.2016.02.028.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">González C. A., Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go.Int J Cancer, 2012; 130:745-53. doi: 10.1002/ijc.26430.</mixed-citation><mixed-citation xml:lang="en">González C. A., Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go.Int J Cancer, 2012; 130:745-53. doi: 10.1002/ijc.26430.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
